- Home
- RSI vs COLL Comparison
RSI vs COLL Comparison
Compare RSI & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSI
- COLL
- Stock Information
- Founded
- RSI 2012
- COLL 2002
- Country
- RSI United States
- COLL United States
- Employees
- RSI N/A
- COLL N/A
- Industry
- RSI Services-Misc. Amusement & Recreation
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- RSI Consumer Discretionary
- COLL Health Care
- Exchange
- RSI Nasdaq
- COLL Nasdaq
- Market Cap
- RSI 1.1B
- COLL 864.7M
- IPO Year
- RSI N/A
- COLL 2015
- Fundamental
- Price
- RSI $11.74
- COLL $28.89
- Analyst Decision
- RSI Strong Buy
- COLL Strong Buy
- Analyst Count
- RSI 9
- COLL 5
- Target Price
- RSI $15.63
- COLL $43.80
- AVG Volume (30 Days)
- RSI 1.3M
- COLL 325.8K
- Earning Date
- RSI 04-30-2025
- COLL 05-08-2025
- Dividend Yield
- RSI N/A
- COLL N/A
- EPS Growth
- RSI N/A
- COLL N/A
- EPS
- RSI 0.10
- COLL 1.25
- Revenue
- RSI $969,062,000.00
- COLL $664,283,000.00
- Revenue This Year
- RSI $15.14
- COLL $19.96
- Revenue Next Year
- RSI $14.38
- COLL $3.93
- P/E Ratio
- RSI $120.45
- COLL $23.01
- Revenue Growth
- RSI 29.86
- COLL 17.17
- 52 Week Low
- RSI $7.91
- COLL $23.23
- 52 Week High
- RSI $16.78
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- RSI 50.94
- COLL 59.59
- Support Level
- RSI $11.12
- COLL $26.72
- Resistance Level
- RSI $12.07
- COLL $27.70
- Average True Range (ATR)
- RSI 0.52
- COLL 1.02
- MACD
- RSI -0.02
- COLL 0.24
- Stochastic Oscillator
- RSI 42.47
- COLL 79.71
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.